Controlant closes a $35 million funding round to advance market expansion and strategic product development

The funding positions Controlant to drive market expansion and strategic product development, leveraging significant opportunities in the ongoing digital transformation of pharma supply chains. In partnership, Controlant strives to empower its customers to reduce waste and ensure patient safety at every step of the supply chain through real-time visibility, automation, and digitalization.

Søren Skou, Chairman of the Board of Directors of Controlant:
“Controlant is at a pivotal moment on its journey, having established itself as a market leader. Through strong shareholder support, we have made significant investments in a foundation including a proven portfolio of pharma-validated, real-time visibility solutions, which has created competitive advantage and helped secure partnerships with the world’s leading pharmaceutical companies and logistics providers.

“While sales and implementation processes are protracted, the fundamental direction of the pharmaceutical sector is unchanged: supply chain digitalization is inevitable. Closing the funding round is an important milestone toward sustainable growth, delivering value for our stakeholders, propelling our customers’ success in a rapidly evolving industry, and realizing zero-waste pharma supply chains.”